Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma

Contributed by: Business Wire

Logo

Images

Dunbar Pharma Plant-Based WaterClear THC™

Business Wire embedded0

Tags

Biotechnology

Natural Resources

Pharmaceutical

Alternative Medicine

Managed Care

General Health

Health

Cannabis

WaterClear THC™

More Like This

Brains Bioceutical Expands Industry-Leading Cannabinoid Offering with D9-THC and CBN, Unveiling New Frontiers for Drug Development

Bloom Announces Early 2026 UK Launch, Expanding into Europe with New Garden Pharma as Exclusive Manufacturer

UK companies celebrate five-year anniversary of medical cannabis legislation with the launch of the BPA

Tilray Medical Publishes Pioneering Research on the Pharmacokinetics of THC and CBD Formulations

PR Newswire associated0

Piramal Pharma Solutions Announces Partnership with Botanix to Support Drug Substance Development

Tilray Medical Welcomes Progress in Germany’s Medical Cannabis Framework and Supports Continued Policy Development

Tilray Medical Receives Approval for First Medical Cannabis Extract in Portugal

PR Newswire associated0

Curaleaf International, in Partnership with Jupiter Research, Secures EU Medical Device Certification for Europe's First Handheld Liquid Inhalation Device